C4 Therapeutics Stock (NASDAQ: CCCC) stock price, news, charts, stock research, profile.
You can purchase shares of C4 Therapeutics (NASDAQ:CCCC) through any online brokerage.
Other companies in C4 Therapeutics’s space includes: Macrogenics (NASDAQ:MGNX), Innate Pharma (NASDAQ:IPHA), 4D Molecular Therapeutics (NASDAQ:FDMT), Voyager Therapeutics (NASDAQ:VYGR) and Monopar Therapeutics (NASDAQ:MNPR).
C4 Therapeutics has a consensus price target of $10.82.
The stock price for C4 Therapeutics (NASDAQ: CCCC) is $3 last updated February 21, 2025 at 4:45 PM EST.
There are no upcoming dividends for C4 Therapeutics.
C4 Therapeutics’s Q1 earnings are confirmed for Wednesday, May 7, 2025.
There is no upcoming split for C4 Therapeutics.
C4 Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.